NFH
EGRX

NEXT Financial Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

NEXT Financial Holdings’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$16K Buy
+315
New +$14K ﹤0.01% 1017

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

NEXT Financial Holdings's EGRX Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2019: 315 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings.

182 funds tracked by Wall St. Rank hold EGRX as of Q1 2019.

  • NEXT Financial Holdings held 315 shares of Eagle Pharmaceuticals, Inc. worth $16K as of Q1 2019.
  • Eagle Pharmaceuticals, Inc. was a new NEXT Financial Holdings position in Q1 2019.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1017 holding.
  • 182 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.